Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.34M Hold
7,792
0.05% 225
2026
Q1
$7.17M Hold
7,792
0.04% 243
2025
Q4
$8.38M Hold
7,792
0.04% 231
2025
Q3
$5.95M Buy
7,792
+2,127
+38% +$1.58M 0.03% 261
2025
Q2
$4.42M Hold
5,665
0.02% 277
2025
Q1
$4.68M Hold
5,665
0.02% 278
2024
Q4
$4.37M Hold
5,665
0.03% 289
2024
Q3
$5.02M Sell
5,665
-5,770
-50% -$5.19M 0.02% 275
2024
Q2
$10.3M Hold
11,435
0.04% 192
2024
Q1
$8.9M Buy
+11,435
New +$8.14M 0.03% 216

Other funds holding LLY

M&G plc's LLY Position: Q2 2026 in Review

M&G plc held its Eli Lilly (LLY) position steady in Q2 2026 at 7,792 shares worth $9.34M. The position accounts for 0.05% of the portfolio, ranked #225.

M&G plc first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.3M in Q2 2024. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • M&G plc held 7,792 shares of Eli Lilly worth $9.34M as of Q2 2026.
  • M&G plc left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.05% of M&G plc's portfolio in Q2 2026, its #225 holding.
  • M&G plc first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • M&G plc's Eli Lilly position peaked at $10.3M in Q2 2024.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.